i-Tail announces innovation strategy, targeting 15% of revenue from innovation in 2026

In response, i-Tail has been accelerating the development of health-driven solutions across its global portfolio, with 548 product innovation SKUs launched in 2024-2025. These efforts underscore i-Tail's long-term ambition to be a leading innovation-driven pet food manufacturer.

Pahk Shewaruksakul, Chief Commercial Officer of i-Tail Corporation PCL, said, "In 2026, the market will continue shifting toward food and treats that deliver clear and credible health benefits for pets. As this trend accelerates, innovation becomes increasingly central to i-Tail's growth and long-term performance. Our innovation strategy is focused on science-led nutrition that supports longevity, fits seamlessly into everyday feeding, and is enjoyable for pets."

Three pillars of i-Tail's innovation strategy

1. Advancing innovation through open collaboration

i-Tail works closely with major global customers from the early stages of concept development, co-creating products that combine market insights with i-Tail's research and development expertise. In parallel, the company partners with the academic and research community to strengthen the scientific foundations of its innovation. In collaboration with five leading universities in Thailand, i-Tail has established research platforms that advance nutrition science by bridging academic insights with real-world product development.

These external partnerships are reinforced by Thai Union Group's innovation ecosystem, including i-Cattery, i-Tail's dedicated feline research facilities, as well as Global PetCare Innovation Center and the Group's Global Innovation Center, to support product development, testing, and scale-up toward commercial launch.

2. Pet food journey toward longevity

As pets are increasingly seen as family members, expectations of pet food are evolving beyond basic nutrition toward long-term health. In response, i-Tail is advancing functional and science-led solutions to support longevity, with the ambition to expand into nutraceuticals and personalized nutrition by 2030.

The company is also scaling health-driven innovations into accessible, everyday formats, to make functional benefits a part of daily diets rather than limited to niche or specialty products. i-Tail integrates a range of functional ingredients across its portfolio, such as protein hydrolysates —high-quality, easily digestible proteins that help reduce the risk of food-related allergies and improve nutrient absorption, as well as seafood-based ingredients like tuna oil and tuna bone calcium, which draw on Thai Union Group's marine nutrition expertise.

These solutions are supported by manufacturing and processing approaches that preserve nutritional integrity and are underpinned by responsible sourcing and traceability.

3. Science-backed innovation with proven palatability

At i-Tail, scientific credibility is paired with real-world enjoyability for pets. This means palatability is embedded as a core research and development principle. The feline research center, i-Cattery, enables structured product testing under real-life conditions, generating insights into feline preferences and ensuring products pets love—while accelerating product development by up to three times. Between 2023 and 2025, i-Tail conducted 795 product tests through i-Cattery for 20 leading global pet food brands.

i-Tail's commitment to responsible, science-led innovation is reinforced by i-Cattery's AAALAC accreditation, the global benchmark for animal welfare. i-Tail is the world's only pet food manufacturer to achieve AAALAC certification, strengthening trust in its products among consumers, partners, and industry stakeholders.

Together, the three pillars of i-Tail's innovation strategy will shape the future of PetCare—advancing responsible, science-led nutrition that enables healthier and happier lives for pets and pet parents.

• ข่าวthe company
• ข่าวo:editor
• ข่าวo:bus
• ข่าวo:loc
• ข่าวen